Laser drilling is commonly used in the production of osmotic-controlled release tablets but is expensive and time-consuming. An alternative is using customized tooling to compress the tablet blend and create the required orifice, which can reduce costs and improve efficiency. This study presents a cost-effective approach using a specially designed notch-enabled tool to replace laser drilling in osmotic tablet manufacturing. A 21 × 10 mm oval-shaped tool with a 0.7 mm notch and tapered dies was designed using S7 material to assess feasibility. Metformin hydrochloride (HCL) osmotic tablets were formulated using controlled notch tooling, eliminating the laser drilling step. Core composition, coating materials, and coating parameters were optimized via full factorial design. The formulation was refined by adjusting the ratios of povidone K29/30 and sodium lauryl sulfate, while the coating used 15% polyethylene glycol with a 90:10 acetone-to-water ratio. The coating process was optimized with specific spray rates and bed temperatures. Tablet evaluation included parameters such as bulk density, disintegration time, hardness, friability, and in vitro dissolution. This approach led to the efficient manufacturing of Metformin HCl extended-release tablets, improving swallowability and minimizing weight gain, without the need for laser drilling. This notch-enabled tooling method shows significant potential for industrial-scale production.
Tiwari KS, Pandey P, Dureja H, Garg M. Enhancing manufacturing efficiency with notch-enabled tooling: Cost-effective osmotically controlled release tablets using metformin HCl. J Appl Pharm Sci. 2025. Online First. http://doi.org/10.7324/JAPS.2025.234050
1. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems: challenges and future directions. Heliyon. 2023;9(6):e17488. https://doi.org/10.1016/j.heliyon.2023.e17488 | |
2. Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22:387-409. https://doi.org/10.1038/s41573-023-00670-0 | |
3. Janczura M, Sip S, Cielecka-Piontek J. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients. Pharm. 2022;14(4):834. https://doi.org/10.3390/pharmaceutics14040834 | |
4. Quarterman JC, Geary SM, Salem AK. Evolution of drug-eluting biomedical implants for sustained drug delivery. Eur J Pharm Biopharm. 2021;159:21-35. https://doi.org/10.1016/j.ejpb.2020.12.005 | |
5. Ogueri KS, Shamblin SL. Osmotic-controlled release oral tablets: technology and functional insights. Trends Biotechnol. 2022;40(5):606-19. https://doi.org/10.1016/j.tibtech.2021.10.001 | |
6. Almoshari Y. Osmotic pump drug delivery systems - A comprehensive review. Pharm. 2022;15(11):1430. https://doi.org/10.3390/ph15111430 | |
7. Wang Q, Jiao J, Cai Q, Wang Q, Zhou W. Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology. Pharm Dev Technol. 2021;26(10):1120-9. https://doi.org/10.1080/10837450.2021.1998912 | |
8. Laffleur F, Keckeis V. Advances in drug delivery systems: work in progress still needed? Int J Pharm. 2020;2:100050. https://doi.org/10.1016/j.ijpx.2020.100050 | |
9. Apostolova N, Iannantuoni F, Gruevska A, Muntane J, Rocha M, Victor VM. Mechanisms of action of metformin in type 2 diabetes: effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 2020;34:101517. https://doi.org/10.1016/j.redox.2020.101517 | |
10. Guo LX, Liu GE, Chen L, Wang HF, Guo J, Zheng XL, et al. Comparison of clinical efficacy and safety of metformin sustained-release tablet (II) (Dulening) and Metformin tablet (Glucophage) in treatment of Type 2 Diabetes Mellitus. Front Endocrinol. 2021;12:712200. https://doi.org/10.3389/fendo.2021.712200 | |
11. Liu Y, Huyan X, Zhang Q, Qing H, Zhang Q, Wang X, et al. Effects of Food and multiple-dose administration on the pharmacokinetic properties of hr20033, a sustained-release formulation of Henagliflozin and metformin for the treatment of diabetes, in healthy Chinese volunteers. Clin Pharmacol Drug Dev. 2023;12(4):376-84. https://doi.org/10.1002/cpdd.1193 | |
12. Theeuwes F, Higuchi T. Osmatic dispensing device for releasing beneficial agent. US3845770A (1973). | |
13. Almoshari Y. Osmotic pump drug delivery systems - A comprehensive review. Pharm. 2022;15(11):1430. https://doi.org/10.3390/ph15111430 | |
14. Tao Y, Wang Z, Hu S, Feng Y, Yang F, Li G. Improving the quality of laser drilling by assisted process methods of static solution and mist blowing. Micromachines. 2024;15(4):515. https://doi.org/10.3390/mi15040515 | |
15. Ohizua ER, Adeola AA, Idowu MA, Sobukola OP, Afolabi TA, Ishola RO, et al. Nutrient composition, functional, and pasting properties of unripe cooking banana, pigeon pea, and sweetpotato flour blends. Food Sci Nutr. 2017;5(3):750-62. https://doi.org/10.1002/fsn3.455 | |
16. Tzakri T, Rehenbrock L, Senekowitsch S, Rump A, Schick P, Krause J, et al. Determination of gastric water emptying in fasted and fed state conditions using a compression-coated tablet and salivary caffeine kinetics. Pharm. 2023;15(11):2584. https://doi.org/10.3390/pharmaceutics15112584 | |
17. Machado JC, Lange AD, Todeschini V, Volpato NM. Development and validation of a discriminative dissolution method for atorvastatin calcium tablets using in vivo data by LC and UV methods. AAPS PharmSciTech. 2014;15(1):189-97. https://doi.org/10.1208/s12249-013-0053-z | |
18. Markl D, Zeitler JA. A review of disintegration mechanisms and measurement techniques. Pharm Res. 2017;34(5):890-917. https://doi.org/10.1007/s11095-017-2129-z | |
Year
Month